Devices, methods and applications for improving sleep disorders
By using a device that regulates the release of biological adenosine and a visual and auditory stimulation generator with a frequency of 1-100Hz, the problem of increasing the concentration of biological adenosine and improving sleep disorders has been solved, achieving a non-invasive, safe and effective therapeutic effect, which is applicable to the treatment of a variety of diseases.
Patent Information
- Application Number
- CN202611067225.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-01-10
- Filing Date
- 2023-01-09
- Publication Date
- 2026-11-17
AI Technical Summary
Currently, there are no safe and effective strategies to increase the concentration of biological adenosine or to precisely improve sleep disorders.
A device for regulating the release of biological adenosine is provided, comprising a stimulator for generating 1-100Hz sound and/or 1-100Hz flash and/or full-screen visual stimulation, wherein the visual stimulation generator, such as the flash, is used to deliver visual and/or sound stimulation to the subject, and the release of biological adenosine is promoted by adjusting parameters such as frequency, illuminance, wavelength, and duty cycle.
It provides a non-invasive, low-side-effect, well-tolerated, and effective adenosine release regulation strategy that can improve sleep disorders and is applicable to the treatment of neurological, cardiovascular, and ophthalmic diseases.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
[0001] This application is a divisional application of Chinese patent application No. 2023800250964, filed on January 9, 2023, entitled "Device, Method and Application for Regulating the Release of Biological Adenosine". This Chinese application is the application that entered the Chinese national phase of the PCT international application No. PCT / CN2023 / 071395. Technical Field
[0002] This invention relates to the field of adenosine regulation, and more particularly to devices, methods and applications for improving sleep disorders. Background Technology
[0003] Adenosine and its derivatives are widely distributed in nature and play an indispensable role in the regulation of various biological behaviors. As early as 1997, McCarty's team first reported in "Science" that extracellular adenosine concentration changes with different sleep-wake states, and that the accumulation of adenosine concentration increases sleep pressure, thereby inducing sleep. However, to date, the development of adenosine-based anti-insomnia drugs has not made substantial progress due to problems such as the high expression of adenosine receptors in systemic tissues and organs, significant side effects, poor specificity, and desensitization / tolerance to agonists.
[0004] A 2021 survey report by the Chinese Sleep Research Society shows that approximately 40% of my country's total population suffers from varying degrees of sleep disorders. Chronic and severe insomnia can significantly impair patients' work efficiency and mental and physical health, and the losses caused by various accidents and incidents due to sleep disorders amount to hundreds of billions of yuan annually. Long-term insomnia is also a significant contributing factor to many neuropsychiatric diseases. With my country's rapid economic development, the occurrence of sleep disorders is showing a trend towards widespread prevalence and affecting younger people.
[0005] Currently, the main clinical treatment for insomnia is medication, but this presents key challenges such as the need for continuous medication use, drug dependence, and peripheral side effects. Besides medication, other treatments for insomnia include cognitive behavioral therapy (CBT) and intense pulsed light (IPL) therapy. CBT has limitations and a slow onset of action; while IPL therapy is less effective. Summary of the Invention
[0006] The technical problem this invention aims to solve is that there is currently no safe and effective strategy for increasing the concentration of biological adenosine or for precisely improving sleep disorders.
[0007] In order to solve the above-mentioned technical problems, the inventors discovered that flashing light stimulation can effectively increase the concentration of adenosine in the brain, thereby providing an effective strategy for improving sleep disorders.
[0008] Specifically, the present invention proposes the following technical solution: In one aspect, the present invention provides an apparatus for regulating the release of biological adenosine, comprising a stimulator for generating sound at 1-100 Hz and / or for generating flashes of light at 1-100 Hz and / or full-screen visual stimulation.
[0009] The device of the present invention includes a stimulation generator comprising a visual stimulation generator such as a flash of light and / or an acoustic stimulation generator.
[0010] Optionally, the vision generator emits visual stimuli at 20-80 Hz.
[0011] Optionally, the visual stimulation frequency includes one or more of the following: 20 Hz, 25 Hz, 30 Hz, 35 Hz, 40 Hz, 45 Hz, 50 Hz, 55 Hz, 60 Hz, 65 Hz, 70 Hz, 75 Hz and 80 Hz.
[0012] Optionally, the frequency of the visual stimulus includes 30-60 Hz.
[0013] Optionally, the visual stimulation frequency includes one or more of 30 Hz, 35 Hz, 40 Hz, 45 Hz, 50 Hz, 55 Hz and 60 Hz.
[0014] Optionally, the visual stimulus frequency includes 35-45 Hz.
[0015] Optionally, the visual stimulation frequency includes one or more of 35 Hz, 40 Hz and 45 Hz.
[0016] Optionally, the visual stimulus frequency is 40 Hz.
[0017] Optionally, the white light illuminance of the visual stimulus is above 2000 lux.
[0018] Optionally, the wavelength of the monochromatic light used for the visual stimulus is 480~530nm.
[0019] Optionally, the duty cycle of the visual stimulus is 20%-80%, preferably 30%-70%, or 40%-70%, or 45-55%.
[0020] Optionally, the duty cycle of the visual stimulus is selected from one or more of 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, and 80%.
[0021] Optionally, the duty cycle of the visual stimulus is 50%.
[0022] The device of the present invention, wherein the visual stimulus generator includes a lamp and / or a display screen.
[0023] Optionally, the lamp includes a CCFL lamp, an LED lamp, and / or an OLED lamp.
[0024] Optionally, the display screen includes a CCFL display screen, an LED display screen, and / or an OLED display screen.
[0025] Optionally, the lamp emits white light and / or monochromatic light.
[0026] Optionally, the monochromatic light includes one or more of ultraviolet light, blue light, green light, red light, and near-infrared light; preferably blue light and / or green light.
[0027] Optionally, the center wavelength of the ultraviolet light is 315-400 nm; for example, 320-395 nm, or 325-390 nm, or 330-385 nm, preferably 380 nm.
[0028] Optionally, the center wavelength of the blue light is 450~490nm; for example, 455~488nm, or 460~485nm, preferably 480nm.
[0029] Optionally, the center wavelength of the green light is 500nm~560nm; for example, 505nm~555nm, or 510nm~550nm, or 515nm~545nm, or 520nm~540nm, or 525nm~545nm, or 530nm~535nm, preferably 530nm.
[0030] Optionally, the center wavelength of the red light is 600~680 nm; for example, 595~675 nm, or 590~670 nm, or 585~665 nm, or 580~650 nm, preferably 650 nm.
[0031] Optionally, the center wavelength of the near-infrared light is 780~1100 nm; for example, 790~1090 nm, or 800~1080 nm, or 810~1070 nm, or 820~1060 nm, or 830~1050 nm, or 840~1040 nm, or 850~1030 nm, preferably 850 nm.
[0032] Optionally, the white light illuminance is 2-6000 Lux.
[0033] Optionally, the monochromatic illuminance is 2-500 Lux.
[0034] Optionally, the illuminance of the white light emitted by the lamp is 500-3000 Lux.
[0035] Optionally, the illuminance of the white light emitted by the lamp includes one or more of 500 Lux, 1000 Lux, 2000 Lux and 3000 Lux.
[0036] Optionally, the display screen shows a raster image.
[0037] Optionally, the contrast of the raster image is 10%-100%.
[0038] Optionally, the raster image includes one or more of the following: motion raster image, scintillation raster image, scintillation grid image, and flipped raster image.
[0039] Optionally, the contrast of the motion grating is 10%-100%.
[0040] Optionally, the motion grating is oriented from 0 to 180°.
[0041] Optionally, the spatial frequency of the motion grating image is 0.05-30 cycle / deg; for example, 0.05-10 cycle / deg.
[0042] Optionally, the motion speed of the motion grating image is 1-10 Hz.
[0043] Optionally, the contrast of the flip grating is 10%-100%.
[0044] Optionally, the flipping frequency of the flipping grating is 20-60 Hz or 30-50 Hz, preferably 40 Hz.
[0045] Optionally, the spatial frequency of the flip grating is 0.1-30 cpd or 0.1 cpd.
[0046] Optionally, the contrast of the flip grating is 10%-100%, 70-90%, preferably 80%.
[0047] Optionally, the average brightness of the flip grating is 100~500 cd / m². 2 Or 140-180 cd / m 2 or 150-170 cd / m 2 or 160 cd / m 2 .
[0048] Optionally, the contrast of the flashing raster image is 10%-100%.
[0049] Optionally, the frequency of the flashing grid image is 1-100 Hz.
[0050] Optionally, the grid size of the flashing grid image is 0.5-10 deg.
[0051] The device described in this invention includes a mobile phone, a tablet, or a portable wearable device.
[0052] Optionally, the portable wearable device is selected from glasses, goggles, face mask, hat, headband, helmet, bracelet, or watch; optionally, the glasses include VR glasses.
[0053] The device of the present invention includes a frame; optionally, the portable wearable device also includes temples or a headband.
[0054] Optionally, a light is provided at the edge of the lens surrounded by the frame. Optionally, the light includes a CCFL light, an LED light, and / or an OLED light.
[0055] Optionally, a display screen is located at the center of the lens surrounded by the frame. Optionally, the display screen includes a CCFL display screen, an LED display screen, and / or an OLED display screen.
[0056] The apparatus of the present invention includes a monochromatic lamp and a white lamp.
[0057] Optionally, the illuminance of the monochromatic lamp is 2-500 lux.
[0058] Optionally, the illuminance of the white light lamp is 2-6000 lux.
[0059] Optionally, the lamp includes blue light, green light, red light and white light.
[0060] The apparatus of the present invention includes a display screen that displays a raster image, the raster image comprising a vertical motion raster, a horizontal motion raster, and / or a flashing raster.
[0061] Optionally, the vertical motion grating parameter is oriented at 0°; optionally, the vertical motion grating spatial frequency is 0.2 cpd; optionally, the vertical motion grating temporal frequency is 1 Hz; optionally, the vertical motion grating contrast is 50%.
[0062] Optionally, the horizontal motion grating parameter is oriented at 90°; optionally, the horizontal motion grating spatial frequency is 0.2 cpd; optionally, the horizontal motion grating temporal frequency is 1 Hz; optionally, the horizontal motion grating contrast is 50%.
[0063] In another aspect, the invention also provides the use of any of the above-described devices, the use including for promoting the release of biological adenosine.
[0064] Optionally, the use includes increasing adenosine concentrations in an organism.
[0065] Optionally, the use includes increasing the extracellular adenosine concentration in neurons.
[0066] Optionally, the uses include the treatment of neurological diseases, cardiovascular diseases, and / or ophthalmic diseases.
[0067] Optionally, the neurological disorders include Parkinson's disease, depression, anxiety, dementia, Alzheimer's disease, post-traumatic stress disorder, ADHD, childhood autism, and / or attention deficit.
[0068] Optionally, the cardiovascular disease includes coronary heart disease and / or arrhythmia.
[0069] Optionally, the ophthalmic diseases include myopia, strabismus and amblyopia, age-related retinopathy, etc.
[0070] Optionally, the use includes improving sleep disorders. Optionally, sleep disorders are improved through visual stimulation at 20-80 Hz. Optionally, sleep disorders are improved through visual stimulation at 30-60 Hz. Optionally, sleep disorders are improved through visual stimulation at 35-45 Hz. Optionally, sleep disorders are improved through visual stimulation at 40 Hz.
[0071] Another aspect of the present invention provides a method for regulating the release of biological adenosine, comprising the following steps: Using any of the devices described above, a stimulus of 1-100 Hz is delivered to a subject, wherein the delivery is non-invasive. Optionally, the stimulus includes visual and / or auditory stimulation.
[0072] Optionally, the visual stimulus frequency is 1-100 Hz; alternatively, the visual stimulus frequency is 20-80 Hz.
[0073] Optionally, the visual stimulation frequency includes one or more of the following: 20 Hz, 25 Hz, 30 Hz, 35 Hz, 40 Hz, 45 Hz, 50 Hz, 55 Hz, 60 Hz, 65 Hz, 70 Hz, 75 Hz and 80 Hz.
[0074] Optionally, the frequency of the visual stimulus includes 30-60 Hz.
[0075] Optionally, the visual stimulation frequency includes one or more of 30 Hz, 35 Hz, 40 Hz, 45 Hz, 50 Hz, 55 Hz and 60 Hz.
[0076] Optionally, the visual stimulus frequency includes 35-45 Hz.
[0077] Optionally, the visual stimulation frequency includes one or more of 35 Hz, 40 Hz and 45 Hz.
[0078] Optionally, the visual stimulus frequency is 40 Hz.
[0079] Optionally, the white light illuminance of the visual stimulus is above 2000 lux.
[0080] Optionally, the wavelength of the monochromatic light used for the visual stimulus is 480~530nm.
[0081] Optionally, the duty cycle of the visual stimulus is 20%-80%, preferably 30%-70%, or 40%-70%, or 45-55%.
[0082] Optionally, the duty cycle of the visual stimulus is selected from one or more of 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, and 80%.
[0083] Optionally, the duty cycle of the visual stimulus is 50%.
[0084] The method of the present invention, wherein the visual stimulus includes flashing light stimulation and / or image stimulation.
[0085] Optionally, the flash includes white light and / or monochromatic light.
[0086] Optionally, the image may include a raster image.
[0087] The method of the present invention, wherein the monochromatic light includes one or more of ultraviolet light, blue light, green light, red light and near-infrared light, preferably blue light and / or green light.
[0088] Optionally, the center wavelength of the ultraviolet light is 315~400nm. Optionally, the center wavelength of the blue light is 450~490nm. Optionally, the center wavelength of the green light is 500nm~560nm. Optionally, the center wavelength of the red light is 600~680nm. Optionally, the center wavelength of the near-infrared light is 780~1100nm.
[0089] Optionally, the center wavelength of the ultraviolet light is 320-395 nm, or 325-390 nm, or 330-385 nm.
[0090] Optionally, the center wavelength of the blue light is 455~488nm or 460~485nm.
[0091] Optionally, the center wavelength of the green light is 505nm~555nm, or 510nm~550nm, or 515nm~545nm, or 520nm~540nm, or 525nm~545nm, or 530nm~535nm.
[0092] Optionally, the center wavelength of the red light is 595~675 nm, or 590~670 nm, or 585~665 nm, or 580~650 nm.
[0093] Optionally, the center wavelength of the near-infrared light is 790~1090 nm, or 800~1080 nm, or 810~1070 nm, or 820~1060 nm, or 830~1050 nm, or 840~1040 nm, or 850~1030 nm.
[0094] Optionally, the center wavelength of the ultraviolet light is 380 nm; the center wavelength of the blue light is 480 nm; the center wavelength of the green light is 530 nm; the center wavelength of the red light is 650 nm; and the center wavelength of the near-infrared light is 850 nm.
[0095] Optionally, the white light illuminance is 2-6000 Lux.
[0096] Optionally, the monochromatic illuminance is 2-500 Lux.
[0097] Optionally, the illuminance of the white light emitted by the lamp is 500-3000 Lux. Optionally, the illuminance of the white light emitted by the lamp includes one or more of 500 Lux, 1000 Lux, 2000 Lux and 3000 Lux.
[0098] In the method described in this invention, the contrast of the grating image is 10%-100%.
[0099] Optionally, the raster image includes one or more of the following: motion raster image, scintillation raster image, scintillation grid image, and flipped raster image.
[0100] Optionally, the contrast of the motion grating is 10%-100%.
[0101] Optionally, the motion grating is oriented from 0 to 180°.
[0102] Optionally, the spatial frequency of the motion grating image is 0.05-30 cycles / degree.
[0103] Optionally, the motion speed of the motion grating image is 1-10 Hz.
[0104] Optionally, the contrast of the flip grating is 10%-100%.
[0105] Optionally, the flipping frequency of the flipping grating is 20-60 Hz or 30-50 Hz, preferably 40 Hz.
[0106] Optionally, the spatial frequency of the flip grating is 0.1-30 cpd or 0.1 cpd.
[0107] Optionally, the contrast of the flip grating is 10%-100%, 70-90%, preferably 80%.
[0108] Optionally, the average brightness of the flip grating is 100~500 cd / m². 2 Or 140-180 cd / m 2 or 150-170 cd / m 2 or 160 cd / m 2 .
[0109] Optionally, the contrast of the flashing raster image is 10%-100%.
[0110] Optionally, the frequency of the flashing grid image is 1-100 Hz.
[0111] Optionally, the grid size of the flashing grid image is 0.5-10 degrees.
[0112] Another aspect of the present invention provides a method for evaluating the therapeutic effect of a drug or medical device, including analyzing changes in adenosine concentration in a living organism.
[0113] The evaluation method described in this invention refers to a drug or medical device used to treat neurological diseases, cardiovascular diseases, and / or improve sleep disorders.
[0114] Optionally, the neurological disorders include Parkinson's disease, depression, anxiety, dementia, Alzheimer's disease, post-traumatic stress disorder, ADHD, childhood autism, and / or attention deficit.
[0115] Optionally, the cardiovascular disease includes coronary heart disease and / or arrhythmia.
[0116] Optionally, the evaluation method described in this invention includes analyzing changes in extracellular adenosine concentration in neurons.
[0117] The beneficial effects of this invention include: (1) This invention provides a novel strategy for regulating adenosine release, which has the potential advantages of being non-invasive, having few side effects, being well-tolerated, and having good efficacy; (2) This invention provides a novel strategy for improving sleep disorders. The effect of promoting sleep through adenosine on the central nervous system of the brain is relatively small, the effect is mild, the safety is relatively good, and the probability of central nervous system side effects is low.
[0118] (3) The present invention provides a portable wearable device that is convenient for subjects to use anytime and anywhere. Attached Figure Description
[0119] Figure 1 Example 1 illustrates the effect of ultra-high performance liquid chromatography (UHPLC) on the promoting effect of 40 Hz flash illumination on the total concentration of adenosine in the visual primer cortex (V1).
[0120] Figure 2 The following diagram illustrates the effects of different frequencies of flash stimulation on adenosine release in the V1 region in Example 1: A. Schematic diagram of the experiment detecting adenosine signals in the V1 region of the visual cortex after flash stimulation; B. 40 Hz flash stimulation can effectively induce γ oscillations in the V1 region of the visual cortex; C. Optogenetic (40 Hz) activation of positive neurons in the V1 region (Parvalbumin, PV) of the visual cortex effectively increases adenosine release; D. Time-adenosine release curves in the V1 region of the visual cortex under different frequencies (20 Hz, 40 Hz, 80 Hz) of flash stimulation (n=3-5 / group).
[0121] Figure 3 This illustrates the effect of flash stimulation on the concentrations of serotonin and acetylcholine in the primary visual cortex (V1) brain region in Example 2.
[0122] Figure 4 Example 3 illustrates the brain region-specific increase in adenosine release from the 40 Hz flash. A. Time-adenosine concentration changes in eight brain regions after 30 min of 40 Hz flash stimulation: basal forebrain (BF), visual cortex V1, nucleus accumbens (NAC), ventral tegmental nucleus (VTA), superior colliculus (SC), medial prefrontal cortex (mPFC), hippocampus (HPC), and dorsomedial striatum (DMS).
[0123] Figure 5This section illustrates the increase in extracellular adenosine specificity in the visual cortex under different visual stimulation modes in Example 4. A, Time-concentration curves of adenosine release in the V1 region of the visual cortex under different wavelengths of 40 Hz flash stimulation; B, Visual stimulation with a flashing light rake (flipping grating) significantly increases adenosine release in the V1 region of the visual cortex; A and C, n=3-5 per group; C, Time-concentration curves of adenosine release in the V1 region of the visual cortex under different motion grating visual stimulation modes. Circular symbols indicate a rapid increase in adenosine release in the V1 region of the visual cortex with stimulation under the vertically orthogonally inhibited motion grating stimulation mode; square symbols indicate a slow increase in adenosine release in the V1 region of the visual cortex under the full-screen 90° azimuth motion grating stimulation mode; Random symbols indicate no increase in adenosine release under the full-screen random azimuth motion grating stimulation mode. The shaded area represents the visual stimulation time, n=3 per group.
[0124] Figure 6 Example 5 illustrates the effect of 40Hz stroboscopic flicker with different duty cycles on extracellular adenosine in the visual cortex.
[0125] Figure 7 Example 6 illustrates the effect of 40Hz stroboscopic light at different illuminance levels on extracellular adenosine in the visual cortex.
[0126] Figure 8 Example 6 illustrates the effect of 40Hz strobe at different wavelengths on extracellular adenosine in the visual cortex.
[0127] Figure 9 The figures show: Example 7: 40 Hz significantly reduced nocturnal motor activity in mice via adenosine signaling; AC: Time-motor activity curves of mice after 30 minutes of normal white light, 20 Hz, 40 Hz, and 80 Hz flash; DF: Statistical analysis of motor activity in mice during the first 7 hours of the night after 30 minutes of normal white light, 20 Hz, 40 Hz, and 80 Hz flash; G: Intraperitoneal injection of the balanced nucleotide transporter (ENT) inhibitor dipyridamole (dipyr, 15 mg / kg) blocked the motor inhibition effect of 40 Hz flash in CD73-KO mice; H: Intraperitoneal injection of the adenosine A1 receptor antagonist DPCPX (6 mg / kg) blocked the motor inhibition effect induced by 40 Hz flash. n=8 / group, *p<0.05, **p<0.01 v: Normal white light group.
[0128] Figure 10The diagram shows that in Example 8, 40 Hz flash significantly increased the amount of sleep in mice at night; AB, schematic diagrams of EEG and EMG spectra of mice after receiving light treatment for the last 30 minutes of the daytime phase; C, time-sleep volume curve showing that 40 Hz flash significantly increased the amount of sleep in mice at night; D, statistical graph of sleep volume in the first 3 hours of the nighttime phase after light treatment; E, distribution map of sleep energy spectral density of mice at night after light treatment, showing that 40 Hz flash increased the amount of sleep in mice without affecting the spectral energy density; n=7, **p<0.01, ***p<0.001, vs normal white light group; FG: 20Hz and 80Hz flash treatments did not significantly increase the amount of sleep in mice.
[0129] Figure 11 Example 8 shows that cortical injection of adenosine can increase the total amount of sleep in mice in a concentration-dependent manner.
[0130] Figure 12 The diagram shows the distribution of tolerance scores in Example 9.
[0131] Figure 13 The example in Example 10 illustrates how the 40 Hz flash improves several sleep parameters in patients with chronic insomnia, including sleep latency, total sleep time, and wakefulness after falling asleep.
[0132] Figure 14 The example in Example 11 shows that after plantar electroshock, the reactivity of astrocytes was significantly reduced by 40% compared with the control side (AAV2 / 9-GfaABC1D-mCherry), indicating that the AAV2 / 9-GfaABC1D-mCherry-hPMCA2w / b virus can indeed reduce the activity of astrocytes.
[0133] Figure 15 Example 11 illustrates the effect of 40 Hz flash stimulation on extracellular adenosine concentration in astrocytes.
[0134] Figure 16 This illustrates the effect of 40Hz flash stimulation on the extracellular adenosine concentration of neurons in Example 11.
[0135] Figure 17 : This shows a schematic diagram of the portable visual stimulation device in Example 12.
[0136] Figure 18 : Schematic diagram of motion grating stimulation pattern. The grating consists of alternating black and white stripes that move in the direction of the arrows in the diagram.
[0137] Figure 19 : Schematic diagram of raster image changes: Local bright and dark areas of the raster (taking the dotted line as an example) alternate at a frequency of 40Hz; the screen refresh rate is 120Hz.
[0138] Figure 20 : Schematic diagram of a blinking grid. Detailed Implementation
[0139] As described above, the purpose of this invention is to provide a device for regulating the release of biological adenosine, thereby solving the technical problem that there is currently no safe and effective strategy for increasing the concentration of biological adenosine or precisely improving sleep disorders.
[0140] The technical solution of the present invention will now be clearly and completely described. Obviously, based on the specific embodiments of the present invention, all other embodiments obtained by those skilled in the art without inventive effort are within the scope of protection of the present invention.
[0141] It should be noted that the terminology used herein is for the purpose of describing particular implementations only and is not intended to limit the exemplary implementations of the present invention.
[0142] Cold cathode fluorescent lamps (CCFLs) have advantages such as high power and high brightness, and are widely used in displays, lighting and other fields.
[0143] A light-emitting diode (LED) is a commonly used light-emitting device.
[0144] Organic light-emitting diodes (OLEDs) are a type of current-driven organic light-emitting device.
[0145] This invention provides a device for regulating the release of biological adenosine, comprising a stimulus generator for generating sound at 1-100 Hz and / or flashing light and / or full-screen visual stimulation at 1-100 Hz. The stimulus generator may include, for example, a flashing stimulus (emitted via a strobe or grating device), a visual stimulus generator, and / or a sound stimulus generator. Optionally, the visual generator emits visual stimulation at 20-80 Hz, for example, at 30-60 Hz, or at 35-45 Hz, or for example, at one or more of the following frequencies: 20 Hz, 25 Hz, 30 Hz, 35 Hz, 40 Hz, 45 Hz, 50 Hz, 55 Hz, 60 Hz, 65 Hz, 70 Hz, 75 Hz, and 80 Hz. Optionally, the visual stimulus frequency is 40 Hz. Optionally, the white light illuminance of the visual stimulus is above 2000 lux; optionally, the monochromatic light wavelength of the visual stimulus is 480~530 nm; optionally, the duty cycle of the visual stimulus is 20%-80%, preferably 30%-70%, or 40%-70%, or 45-55%; optionally, the duty cycle of the visual stimulus is selected from one or more of 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75% and 80%; optionally, the duty cycle of the visual stimulus is 50%.
[0146] The generator providing visual stimulation includes lamps and / or displays; optionally, the lamps include CCFL lamps, LED lamps and / or OLED lamps; optionally, the displays include CCFL displays, LED displays and / or OLED displays.
[0147] According to the device provided by the present invention, the stimulation generator can emit white light and / or monochromatic light; optionally, the monochromatic light includes one or more of ultraviolet light, blue light, green light, red light, and near-infrared light; optionally, the center wavelength of the ultraviolet light is 315-400 nm, 320-395 nm, or 325-390 nm, or 330-385 nm; preferably 380 nm; the center wavelength of the blue light is 450-490 nm, or 455-488 nm, or 460-485 nm; preferably 480 nm; the center wavelength of the green light is 500 nm-560 nm, or 505 nm-555 nm, or 510 nm-550 nm, or 515 nm-545 nm, or 520 nm-540 nm, or 525 nm-545 nm, or 530 nm-535 nm; preferably 530 nm; the center wavelength of the red light is 600-680 nm. The wavelength of the near-infrared light is 780-1100 nm, 790-1090 nm, 800-1080 nm, 810-1070 nm, 820-1060 nm, 830-1050 nm, 840-1040 nm, or 850-1030 nm; preferably 850 nm. Optionally, the white light illuminance is 2-6000 Lux, and the monochromatic light illuminance is 2-500 Lux. Optionally, the illuminance of the white light emitted by the lamp is 500-3000 Lux; optionally, the illuminance of the white light emitted by the lamp includes one or more of 500 Lux, 1000 Lux, 2000 Lux, and 3000 Lux.
[0148] Different colors and wavelengths of light will produce different stimulating effects. By adjusting the color, wavelength, frequency, and other parameters of the light emitted by the device, it can be used to treat different diseases.
[0149] According to the apparatus provided by the present invention, the stimulus generator can emit grating image stimuli; optionally, the contrast of the grating image is 10%-100%; optionally, the grating image includes one or more of a motion grating image, a flashing grating image, a flashing grid image, and a flipping grating image; optionally, the contrast of the motion grating is 10%-100%; optionally, the orientation of the motion grating is 0-180°; optionally, the spatial frequency of the motion grating image is 0.05-30 cycles / deg; for example, 0.05-10 cycles / deg; optionally, the motion speed of the motion grating image is 1-10 Hz. Optionally, the motion grating may include a vertical motion grating or a horizontal motion grating. The vertical motion grating parameters are: orientation 0°, spatial frequency 0.2 cpd, temporal frequency 1 Hz, and contrast 50%; the horizontal motion grating parameters are: orientation 90°, spatial frequency 0.2 cpd, temporal frequency 1 Hz, and contrast 50%. Optionally, the contrast of the flickering grating image is 10%-100%; optionally, the frequency of the flickering grating image is 1-100 Hz; optionally, the grating size of the flickering grating image is 0.5-10 deg.
[0150] like Figures 17-19 As shown, the present invention provides different gratings. Figure 17 This is a schematic diagram of the motion grating stimulation mode provided by the present invention. The variable parameters include: 100~500 candela per square meter (cd / m²). 2 ), orientation (0-180°), spatial frequency (0.2-30 cycles / degree, i.e., cpd, the width of a single grating), temporal frequency (1-10Hz, the speed of grating movement), contrast (1-100%), stimulation range size (0-30° or full-screen stimulation), orthogonal stimulation (central receptive field 5°, peripheral receptive field 15°).
[0151] Figure 18 This is a schematic diagram of the flip-grating stimulation mode provided by the present invention. The variable parameters include: 100~500 candela per square meter (cd / m²). 2 ), orientation (0-180°), spatial frequency (0.1-30 cycles / degree, i.e., cpd, single grating width), flicker frequency (1~100Hz), contrast (1-100%), stimulation range size (0-30° or full-screen stimulation).
[0152] Figure 19 The flickering grid stimulation mode provided by this invention is presented on a display screen in a checkerboard grid pattern, with variable parameters: the length and width of a single black / white grid (1°~5°), contrast ratio (1%~100%), and flicker frequency (1~100Hz). Contrast ratio refers to the measurement of different brightness levels between the brightest white and the darkest black areas in an image. A larger difference range indicates a higher contrast (e.g., 100% contrast), and a smaller difference range indicates a lower contrast (e.g., 10% contrast). Higher contrast ratios are easier for the naked eye to distinguish.
[0153] This invention provides a device for regulating the release of biological adenosine, wherein the device includes a mobile phone, tablet, or portable wearable device. The portable wearable device may be, for example, eyeglasses, goggles, face mask, hat, headband, helmet, bracelet, or watch; optionally, the eyeglasses include VR glasses. Optionally, the portable wearable device includes a frame; optionally, the portable wearable device also includes temples or a headband; optionally, a light is provided at the edge of the lens surrounded by the frame; optionally, the light includes a CCFL light, an LED light, and / or an OLED light; optionally, a display screen is provided at the center of the lens surrounded by the frame; optionally, the display screen includes a CCFL display screen, an LED display screen, and / or an OLED display screen.
[0154] The device provided by this invention can be used to promote the release of biological adenosine; for example, to increase the concentration of adenosine in a living organism; in particular, to increase the concentration of extracellular adenosine in neurons.
[0155] Adenosine and its receptors have been extensively studied and recognized for their potential therapeutic applications in treating numerous diseases of the nervous and cardiovascular systems. These include neurological disorders such as Parkinson's disease, depression, anxiety, dementia, Alzheimer's disease, post-traumatic stress disorder, ADHD, childhood autism, and attention deficit hyperactivity disorder; and cardiovascular diseases such as coronary heart disease and arrhythmias. Since the device of this invention can effectively increase the concentration of adenosine in the brain, it is anticipated that this device can also be used to treat many diseases of the nervous and cardiovascular systems.
[0156] The device of this invention can be used to treat neurological diseases, cardiovascular diseases, and / or ophthalmic diseases; optionally, the neurological diseases include Parkinson's disease, depression, anxiety, dementia, Alzheimer's disease, post-traumatic stress disorder, ADHD, childhood autism, and / or attention deficit; optionally, the cardiovascular diseases include coronary heart disease and / or arrhythmia; optionally, the ophthalmic diseases include myopia, strabismus, amblyopia, and age-related retinopathy. The device provided by this invention can be used to improve sleep disorders; optionally, sleep disorders are improved through 20-80 Hz visual stimulation, through 30-60 Hz visual stimulation, through 35-45 Hz visual stimulation, or through 40 Hz visual stimulation.
[0157] This invention provides a method for regulating the release of biological adenosine, comprising the following steps: Using the device provided by this invention, a stimulus of 1-100 Hz is delivered to a subject, wherein the delivery is non-invasive; optionally, the stimulus includes visual stimulation and / or auditory stimulation. Optionally, the visual stimulus frequency is 1-100 Hz, or alternatively, the visual stimulus frequency is 20-80 Hz, for example 30-60 Hz, for example 35-45 Hz; the visual stimulus frequency includes one or more of 20 Hz, 25 Hz, 30 Hz, 35 Hz, 40 Hz, 45 Hz, 50 Hz, 55 Hz, 60 Hz, 65 Hz, 70 Hz, 75 Hz, and 80 Hz. Optionally, the visual stimulus frequency is 40 Hz. Optionally, the white light illuminance of the visual stimulus is 2000 lux or higher; optionally, the monochromatic light wavelength of the visual stimulus is 480-530 nm; optionally, the duty cycle of the visual stimulus is greater than 10%; optionally, the duty cycle of the visual stimulus is 20%-80%, preferably 30%-70%, or 40%-70%, or 45-55%; optionally, the duty cycle of the visual stimulus is selected from one or more of 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, and 80%; optionally, the duty cycle of the visual stimulus is 50%.
[0158] Optionally, in the method for regulating the release of biological adenosine of the present invention, the visual stimulus includes flashing light stimulation and / or image stimulation; optionally, the flashing light includes white light and / or monochromatic light; optionally, the image includes a raster image. Optionally, the monochromatic light includes one or more of ultraviolet light, blue light, green light, red light, and near-infrared light; optionally, the center wavelength of the ultraviolet light is 315-400 nm; optionally, the center wavelength of the ultraviolet light is 320-395 nm, or 325-390 nm, or 330-385 nm; the center wavelength of the blue light is 450-490 nm; optionally, the center wavelength of the blue light is 455-488 nm, or 460-485 nm; the center wavelength of the green light is 500 nm-560 nm; optionally, the center wavelength of the green light is 505 nm-555 nm, or 510 nm-550 nm, or 515 nm-545 nm, or 520 nm-540 nm, or 525 nm-545 nm, or 530 nm-535 nm; and the center wavelength of the red light is 600-680 nm. nm; Optionally, the red light center wavelength is 595~675 nm, or 590~670 nm, or 585~665 nm, or 580~650 nm; the near-infrared light center wavelength is 780~1100 nm; Optionally, the near-infrared light center wavelength is 790~1090 nm, or 800~1080 nm, or 810~1070 nm, or 820~1060 nm, or 830~1050 nm, or 840~1040 nm, or 850~1030 nm. Optionally, the ultraviolet light center wavelength is 380 nm; the blue light center wavelength is 480 nm; the green light center wavelength is 530 nm; the red light center wavelength is 650 nm; the near-infrared light center wavelength is 850 nm; Optionally, the white light illuminance is 2-6000 Lux, and the monochromatic light illuminance is 2-500 Lux. Optionally, the illuminance of the white light emitted by the lamp is 500-3000 Lux. Optionally, the illuminance of the white light emitted by the lamp includes one or more of 500 Lux, 1000 Lux, 2000 Lux and 3000 Lux.Optionally, the contrast of the grating image is 10%-100%; optionally, the grating image includes one or more of the following: a moving grating image, a scintillation grating image, a scintillation grid image, and a flipped grating image; optionally, the contrast of the moving grating is 10%-100%; optionally, the orientation of the moving grating is 0-180°; optionally, the spatial frequency of the moving grating image is 0.05-30 cycles / degree; optionally, the motion speed of the moving grating image is 1-10 Hz; optionally, the contrast of the scintillation grid image is 10%-100%; optionally, the frequency of the scintillation grid image is 1-100 Hz; optionally, the grid size of the scintillation grid image is 0.5-10 degrees. Optionally, the method for regulating the release of biological adenosine of the present invention can increase the extracellular adenosine concentration of neurons.
[0159] This invention provides a method for evaluating the therapeutic effects of drugs or medical devices, including analyzing changes in adenosine concentrations inside a living organism (e.g., in brain regions such as the visual cortex (V1), basal forebrain (BF), and superior colliculus (SC), and / or intracellular and extracellular cells such as neurons). The drug or medical device is used to treat neurological diseases, cardiovascular diseases, and / or improve sleep disorders; optionally, the neurological diseases include Parkinson's disease, depression, anxiety, dementia, Alzheimer's disease, post-traumatic stress disorder, ADHD, childhood autism, and / or attention deficit; optionally, the cardiovascular diseases include coronary heart disease and / or arrhythmias.
[0160] The adenosine regulation device and sleep disorder improvement scheme of the present invention will be illustrated below through specific embodiments.
[0161] Example 1. Frequency-dependent increase in adenosine concentration in the V1 region by 40 Hz flash stimulation. 1) Ultra-high performance liquid chromatography analysis showed that 40Hz flash illumination significantly increased the total concentration of vitamin A1 adenosine. The total concentration of adenosine in the visual cortex of mice was determined using ultra-high performance liquid chromatography (UHPLC) (literature reports suggest it includes 95% extracellular adenosine and 5% intracellular adenosine). Thirty minutes before light exposure, mice were intraperitoneally injected with 6 mg / kg of the adenosine transporter inhibitor dipyridamole (Dipyr) dissolved in 0.5% methylcellulose. The control group received 0.5% methylcellulose. Thirty minutes after injection, both the blank control group and the dipyridamole group were exposed to light at 3000 lux, a duty cycle of 50%, and a 40 Hz stroboscopic stimulation (hereinafter referred to as "40 Hz stroboscopic stimulation") for 30 minutes. Immediately after light exposure, samples were collected, weighed, and rapidly frozen in liquid nitrogen. After sample processing, the peak value around 2.0 was measured using the reference standard parameters. The area under the curve at this peak value was used as the adenosine concentration. Finally, the adenosine concentration was calibrated by checking the sample quality.
[0162] The results are as follows Figure 1 As shown, flash stimulation significantly increased adenosine concentration (p=0.0245, n=7), while dipyridamole effectively inhibited the total intracellular and extracellular adenosine concentration. After 30 minutes of 40Hz flash illumination, the inhibition of total intracellular and extracellular adenosine concentration by dipyridamole was effectively reversed (p=0.0431, n=7). This indicates that 30 minutes of 40Hz flash illumination significantly increases adenosine concentration in the V1 region and also significantly increases adenosine concentration in the dipyridamole group.
[0163] 2) Frequency dependence This experiment employed a novel genetically encoded adenosine probe with high specificity and high temporal resolution to investigate adenosine dynamics changes in different brain regions at different frequencies. The working principle of the novel adenosine probe is as follows: upon activation of the cellular adenosine G protein-coupled receptor, the concentration change of extracellular adenosine is measured by the fluorescence intensity of green fluorescent protein. Figure 2 As shown in Figure A, we stereotactically injected the adenosine probe (AAV2 / 9-hsyn-GRABAdo1.0, Wuhan Shumi Brain Science Technology Co., Ltd., PT-1348) and the adenosine probe control mutant (AAV2 / 9-hsyn-GRABAdo-mut, Wuhan Shumi Brain Science Technology Co., Ltd., PT-1348) into the primary visual cortex (V1) of mice (3.6 μm anterior, ±2.4 μm lateral, -0.6 μm depth). After 3 weeks of rearing, the mice were exposed to a flashing environment of 20 Hz, 40 Hz, and 80 Hz (12.5 ms light on, 12.5 ms light off, i.e., 50% duty cycle, 3000 lux, 60 watts) for 30 min, and the changes in adenosine concentration before and after flash exposure were compared.
[0164] The results are as follows Figure 2 As shown, Figure 2 As shown in B, a 40 Hz flash can effectively induce γ oscillations in the V1 region. Figure 2 As shown in Figure C, the adenosine concentration increased significantly after 40Hz flash stimulation. Figure 2 D shows the time-adenosine release curves in the V1 region under different frequency (20 Hz, 40 Hz, 80 Hz) flash stimulation (n=3-5 / group). Mice showed a slight increase in adenosine signal under 80 Hz flash stimulation, but no change in adenosine concentration was observed at 20 Hz. This result indicates that the 40 Hz flash frequency-dependent activation of V1 region cells releases adenosine. In summary, extracellular adenosine release may be related to specific light frequencies, which will provide an important neurochemical basis for exploring the effects of visual stimulation on sleep and cognitive impairment.
[0165] Example 2. Flash stimulation specifically alters adenosine in the primary visual cortex (V1) without altering the neurotransmitters serotonin and acetylcholine in the primary visual cortex (V1). Neurotransmitters and neuromodulators are key mediators of communication between neurons, enabling effective information transmission and integration. To verify whether 40 Hz flash stimulation specifically alters adenosine in the primary visual cortex (V1), we used a genetically encoded fluorescent probe combined with a fiber optic recording system to detect the dynamic changes of serotonin (5-HT) and acetylcholine (ACh) during 40 Hz flash stimulation.
[0166] We use AAV9-hsyn-GRAB 5-HT3.5 and AAV9-hsyn-GRAB 5HT2.1-mut AAV9-hsyn-GRAB ACh3.0 and AAV9-hSyn-GRAB ACh3.0-mut Injected into the left and right sides of the mouse visual cortex respectively ( Figure 3 (AB) After two weeks of viral expression, a 40 Hz flash intervention was performed, and the concentration changes of serotonin and acetylcholine were recorded in real time. The experimental results are as follows: Figure 3 As shown in CD, after 40Hz flash stimulation, there were no significant changes in 5-HT and Ach in the visual cortex (V1).
[0167] Example 3. 40 Hz flash stimulation can effectively increase adenosine release levels in brain regions such as V1, BF, mPFC, and SC. This phenomenon is brain region specific. This experiment used novel genetically encoded adenosine probes to detect adenosine release levels in brain regions including the visual cortex (V1), basal forebrain (BF), nucleus accumbens (NAc), ventral midbrain tegmentum (VTA), superior colliculus (SC), prefrontal cortex (mPFC), hippocampus (HPC), and dorsolateral striatum (DMS). Figure 4 As shown, after 30 min of 40 Hz flash stimulation, adenosine signals were recorded. We found that adenosine release levels were significantly increased in brain regions such as V1, SC, BF, mPFC, and HPC. In contrast, no increase in adenosine signal was observed in the control group injected with AAV2 / 9-hsyn-Mut virus (Wuhan Shumi Brain Science Technology Co., Ltd., PT-1348). Among the brain regions with elevated adenosine, the strongest adenosine signals were observed in brain regions related to visual information encoding, such as V1 and SC; the adenosine signal in BF, which is related to sleep-wake cycle, was also significantly enhanced; and the adenosine signal in brain regions related to cognition, such as mPFC and HPC, was slightly enhanced. These results indicate that this 40 Hz non-invasive flash stimulation mode can be used to regulate sleep by increasing adenosine levels in sleep-related brain regions.
[0168] Example 4. Different visual stimulation patterns increase V1 adenosine release levels 1) 40Hz flash stimulation like Figure 5 As shown in Figure A, under 40Hz flash stimulation, the difference in adenosine release levels in the V1 region at different wavelengths was observed. Only blue light at wavelengths of 480 nm and green light at wavelengths of 530 nm significantly increased the adenosine concentration in the V1 region, while flash stimulation at other wavelengths (380 nm, 650 nm, 850 nm, etc.) did not increase the adenosine concentration in the V1 region.
[0169] 2) The effect of motion grating like Figure 5 As shown in C, horizontal motion grating stimulation is used ( Figure 18 On the left (arrow indicates direction of motion), the excitation parameters are: the raster is displayed in full screen at high contrast (80%) (average screen brightness is 160 cd / m²). 2 To ensure the mice could see the stimulus throughout the experiment, a horizontal motion grating was used. The spatial frequency of the horizontal motion grating was 0.2 cpd, and the temporal frequency was 1-10 Hz (i.e., the grating motion speed). Simultaneously, a horizontal motion grating was used at a central 5° angle, and a vertical motion grating was used at a peripheral 15° angle (center-peripheral vertical motion grating). Figure 18 The combined stimulation thus formed was used to detect changes in adenosine levels in the V1 region of mice.
[0170] The results showed that both types of motion gratings significantly increased V1 adenosine, but the horizontal motion grating increased it less than the center-periphery vertical motion grating. Figure 5 C, ΔF / F value is 5% for horizontal motion grating and 8% for center-periphery vertical motion grating, indicating that large-scale grating stimulation has a significant impact on extracellular adenosine production.
[0171] 3) The effect of vertically flipped gratings like Figure 5 As shown in Figure B, while keeping the light intensity constant, a vertically flipped grating at a frequency of 40 Hz is used for stimulation. The excitation parameters are: the spatial frequency of the vertical sinusoidal flipped grating is 0.1 cpd, and the flipping frequency is 40 Hz (i.e., a black grating and a white grating flash alternately). Figure 19 Furthermore, within a specific time period (after Gamma correction to eliminate screen brightness nonlinearity), the average light intensity remained unchanged. The raster was displayed full-screen at high contrast (80%) (average screen brightness was 160 cd / m²). 2 This is to ensure that the mice can see the stimulus throughout the experiment.
[0172] The results showed that vertically flipped gratings significantly increased V1 adenosine, but the increase was smaller than that from 40Hz flash stimulation.Figure 5 B, ΔF / F value is 5% for flip grating and 15-20% for 40Hz flash stimulation, indicating that light intensity has a significant impact on the production of extracellular adenosine.
[0173] Example 5. Effects of 40Hz flash stimulation with different duty cycles on extracellular adenosine in the visual cortex Considering the effect of illuminance (total energy) of white flash stimulation on extracellular adenosine concentration, and that different duty cycles (1%, 10%, 50%) of 40Hz flash (at the same illuminance of 3000 lux) produce different total energy, we investigated the effect of 30 minutes of 40Hz flash stimulation (at the same illuminance of 3000 lux) on adenosine levels in the V1 region under different duty cycles (1%, 10%, 50%).
[0174] The results are as follows Figure 6 As shown, under 1% and 10% duty cycle conditions, the peak ΔF / F ratios for increasing V1 adenosine levels are 5 and 10, respectively, which are lower than those for 50% duty cycle stimulation (peak ΔF / F is 25). This indicates that white flash stimulation significantly increases V1 adenosine levels at 50% duty cycle. Therefore, at the same illuminance (3000 lux), white flash stimulation at 40 Hz frequency increases extracellular adenosine concentration in a duty cycle-dependent (1%, 10%, 50%) manner, with 40 Hz flash stimulation being the most significant for increasing V1 adenosine levels at 50% duty cycle.
[0175] Example 6. Effects of 40Hz flicker with different light intensities and wavelengths on extracellular adenosine in the visual cortex. 1) The effect of light intensity The effects of different illuminance levels (50 Lux, 500 Lux, 1000 Lux, 2000 Lux, and 3000 Lux) of 40Hz white flash stimulation on adenosine production in the visual cortex were investigated. Figure 7 As shown, we found that low-intensity (500 Lux) 40Hz flash stimulation induced lower adenosine levels, while high-intensity (3000 Lux) 40Hz white flash stimulation increased adenosine levels with a peak ΔF / F ratio of 20. Furthermore, 40Hz flash stimulation with illuminance above 2000 Lux significantly increased adenosine concentration in the V1 region. In summary, these findings of increasing adenosine levels in the V1 region from white light of different illuminances and vertical gratings indicate that light intensity is a key factor in the generation of extracellular adenosine levels in the primary visual cortex of the brain.
[0176] 2) The effect of light wavelength like Figure 8As shown, under 40Hz monochromatic flash stimulation at an illuminance of 500 Lux, blue light with wavelengths of 480 nm and green light with wavelengths of 530 nm significantly increased the adenosine concentration in the V1 region under 40Hz flash conditions, while flash stimulation at other wavelengths (380 nm, 650 nm, 850 nm, etc.) did not increase the adenosine concentration in the V1 region. It is noteworthy that the kinetics of this single-wavelength increase in V1 adenosine concentration are generally similar (increasing and decreasing from 10 minutes, reaching a peak concentration at 30 minutes, and persisting for 2-3 hours).
[0177] Example 7. 40 Hz flash stimulation inhibits nocturnal motor activity in mice. Building upon our previous work, we found that 40 Hz flash stimulation significantly increased adenosine concentration in the brain region (BF), which plays a crucial role in sleep and wakefulness regulation. Therefore, we hypothesized that 40 Hz flash stimulation could regulate sleep rhythms. We first irradiated wild-type C57BL / 6J mice with flashes of different frequencies during the last 30 minutes of the daytime (19:30-20:00), and then monitored the mice's nocturnal motor activity to indirectly reflect their sleep-wake cycle. Figure 9 As shown, motor activity in mice was inhibited for up to 8 hours after 30 min of 40 Hz flash stimulation; however, flash stimulation at 20 Hz and 80 Hz had no significant effect on motor activity, indicating that the inhibition of nocturnal motor activity by flash stimulation is frequency-specific. To further clarify the source of adenosine produced by 40 Hz flash stimulation, we first conducted a 40 Hz light exposure experiment using CD73-KO mice. We found that 40 Hz flash stimulation still significantly reduced nocturnal motor activity in CD73-KO mice, indicating that extracellular ATP metabolism is not the main source of adenosine in this phenotype. Subsequently, we injected CD73-KO mice intraperitoneally with the nucleotide transporter inhibitor dipyridamole (Dipyr) at 15 mg / kg. The results showed that the motor inhibition effect induced by 40 Hz flash completely disappeared, suggesting that the transport of intracellular adenosine to the extracellular space via nucleotide transporters is the main mechanism for adenosine release stimulated by 40 Hz flash stimulation in this phenotype. Meanwhile, we also injected CD73-KO mice with 6 mg / kg of 1,3-dipropyl-8-cyclopentylxanthine (8-Cyclopentyl-1,3-dipropyl-1H-purine-2,6(3H,7H)-dione, a receptor antagonist for adenosine A1. The results showed that DPCPX could also block the motion inhibition effect induced by 40 Hz flash.
[0178] Example 8. 40 Hz flash stimulation for 30 minutes significantly increased sleep volume in mice by enhancing extracellular adenosine signaling in cortical cells. 1) A 40 Hz flash for 30 minutes significantly increased the amount of sleep in mice. To verify the regulatory effect of 40 Hz flash light on sleep in mice, we used a polysomnography system to record the mice's electroencephalogram (EEG) and electromyography (EMG). Based on the characteristics of different sleep-wake phases, we accurately determined and statistically analyzed the mice's sleep-wake patterns. In this experiment, we used a self-control method. On the first day, mice were exposed to normal white light for the last 30 minutes of the daytime phase, and then the amount of sleep at night was recorded and analyzed. On the second day, mice were exposed to 40 Hz flash light for the last 30 minutes of the daytime phase, and then the amount of sleep at night was recorded and analyzed. Figure 10 As shown in the AE, by comparing the sleep volume of mice over two nights, we found that 40 Hz flash significantly increased the amount of NREM (Nighttime Regulated Sleep) in mice without affecting slow-wave activity during NREM sleep. These results suggest that 40 Hz flash is a good, non-invasive sleep-inducing method that can promote physiological sleep.
[0179] 2) Flash light stimulation significantly increased the amount of sleep in mice, and this effect was frequency-specific. We further demonstrated that the sleep-inducing effect of flashing light is frequency-specific. First, on day 1, baseline EEG / EMG values of mice after normal daytime light exposure were recorded throughout the entire dark phase (7:00 pm - 7:00 am). Then, on days 2, 9, and 16, during the last 30 minutes of the light phase (6:30-7:00 pm within the 7:00 am - 7:00 pm light phase), mice were exposed to flashing light stimulation at three different frequencies (20 Hz, 40 Hz, and 80 Hz; 3000 lux; 50% duty cycle) for 30 minutes each, and EEG / EMG were recorded during the subsequent dark phase.
[0180] By comparing sleep volume during the dark phase after different treatments, it was found that 30 minutes of 40 Hz flashing light produced a strong sleep-inducing effect in mice. This significant sleep-inducing effect mainly occurred in the first 2 hours. Importantly, 20 Hz and 80 Hz flashing light treatments did not significantly increase sleep volume. Figure 10 (FG) demonstrates that the sleep-promoting effect of flashing lights is frequency-specific.
[0181] 3) Injection of adenosine into the visual cortex can increase the total amount of sleep in mice in a concentration-dependent manner. This study aimed to elucidate how increased adenosine concentration in the visual cortex can enhance sleep in mice by locally injecting adenosine into the V1 cortex. Cannulas were implanted bilaterally in the V1 brain regions of C57BL / 6J mice. After approximately 10 days of surgical recovery, the mice were placed in sleep recording cages. Three days after acclimatization, artificial cerebrospinal fluid (ACSF), adenosine 1.5 nmol / side or 4.5 nmol / side (randomized order, 2 μl / side) was injected into the V1 visual cortex at the onset of the nighttime phase on days 1, 4, and 7. EEG / EMG of the mice were recorded.
[0182] By comparing the amount of sleep in mice after different treatments, such as Figure 11 As shown, mice injected with 4.5 nmol / side of adenosine achieved 3 hours of non-rapid eye movement (NREM) sleep during the dark phase, a significant increase compared to the control group. While the 1.5 nmol / side adenosine injection group showed a tendency to promote sleep compared to the control group, the difference was not statistically significant. This indicates that the sleep-promoting effect of locally administered adenosine in the visual cortex is dose- or concentration-dependent, and the experiment suggests that increasing the total sleep volume in mice requires a certain threshold increase in local adenosine levels in the visual cortex.
[0183] Based on the above experiments and the frequency-specific effects on adenosine production and sleep volume, it is supported that 40Hz flash stimulation promotes sleep by enhancing extracellular adenosine signaling in the cortex.
[0184] Example 9. 40 Hz flash stimulation was well tolerated and safe in healthy subjects. To advance the application of 40 Hz flash stimulation in clinical trials, we first recruited 15 healthy volunteers to test the tolerability and safety of the 40 Hz portable flash device in healthy subjects. In this experiment, subjects had their blood pressure and electrocardiogram measured at 8:00 AM the previous morning without eating breakfast, and blood samples were collected for complete blood count and liver and kidney function tests. The following morning at 7:30 AM, the subjects were given 30 minutes of 40 Hz portable flash stimulation, and their blood pressure and electrocardiogram were measured again, blood samples were collected, and complete blood count and liver and kidney function tests were performed. An adverse reaction questionnaire was also completed. Figure 12 As shown, compared with no flash, 40 Hz flash stimulation did not significantly cause adverse reactions in the sensory systems such as the eyes and nose, or in the central nervous system of the brain, indicating that 40 Hz flash stimulation and the portable device have good tolerability. Blood pressure and blood tests also did not reveal any significant abnormal changes in relevant indicators. These results indicate that 40 Hz flash stimulation and the portable device have good tolerability and safety in healthy subjects.
[0185] Table 1. Clinical data of healthy subjects (n=16) Note: Data is presented as mean ± standard deviation / quantity (percentage).
[0186] *Tolerance rating for flashing light, with a maximum score of 5 points. The lower the score, the better the tolerance.
[0187] Abbreviations: BMI: body mass index; SF-36: the MOS-36 item shortform health survey; PSQI: Pittsburgh sleep quality index; Ess: Epworth Sleepiness Scale.
[0188] Table 2 Safety Evaluation Form (Blood and Electrocardiogram Laboratory Tests) Note: Data is presented as mean ± standard deviation (SD) / frequency (percentage). Use paired t-test or chi-square test depending on the data type.
[0189] Table 3 Summary of Adverse Events Example 10. 40Hz flash stimulation improves sleep in patients with chronic insomnia, including multiple sleep parameters such as sleep latency, total sleep time, and wakefulness after falling asleep. Study Objective: This study aims to recruit patients with chronic insomnia and evaluate the therapeutic effect of 40Hz flash stimulation on these patients.
[0190] Study Protocol: From February to December 2022, this study recruited patients from the Second Affiliated Hospital of Wenzhou Medical University who met the diagnostic criteria for chronic insomnia according to the International Classification of Sleep Disorders (ICSD3). Polysomnography (PSG) was used to record patients' sleep. This was a self-controlled design. Baseline sleep was recorded on the first night, and sleep was recorded again on the second day after a 30-minute intervention with 40Hz photic stimulation (3000 lux; 50% duty cycle). The primary endpoint was a significant reduction in sleep latency and a significant improvement in sleep efficiency. Secondary endpoints included a significant increase in total sleep time and a significant reduction in wakefulness and wakefulness after sleep onset.
[0191] Results: This study included 27 patients, aged 9.4 ± 3.1 years, with a BMI of 15.40 (14.50-17.90) kg / m². 2 Of the 14 women (51.85%), 14 were female.
[0192] The study found that 40Hz flash stimulation significantly reduced sleep latency (minutes) compared to baseline (18.5 (10-29.5) vs. 32.50 (15-49.5), p = 0.0233). Figure 13 A). Meanwhile, 40Hz significantly prolonged total sleep time (minutes) (528 (502-560) vs. 459 (411.5-497), p = 0.0002). Figure 13 B), and the time awake after falling asleep (minutes) (35.5 (28-51) vs. 57.5 (40-128.5), p =0.0012) Figure 13 C), and significantly improved sleep efficiency (%) (89.3 (84.8-82.5) vs. 79.6 (73.2-87.5), p =0.0003) Figure 13 D). Significantly reduced REM sleep latency (min) (139.5 (107-182.5) vs. 199 (156.5-239.5), p = 0.0004) Figure 13 F), increased REM sleep percentage (%) (20.2 (17-21.3) vs. 17.4 (11-20.3), p =0.0038) Figure 13 I). Regarding the number of awakenings, the proportion of light sleep and deep sleep in total sleep time had no significant effect (both p>0.05). Figure 13 E,G,H) Study Conclusion: In this self-controlled clinical study of patients with chronic insomnia, 40Hz flashing light stimulation 30 minutes before bedtime significantly shortened sleep latency, significantly prolonged total sleep time, and significantly reduced wakefulness and frequency after falling asleep. Therefore, 40Hz flashing light stimulation 30 minutes before bedtime can significantly improve sleep initiation and sleep maintenance problems in patients with chronic insomnia.
[0193] Example 11. Study on the main cellular sources of extracellular adenosine production induced by 40Hz flash stimulation Under normal conditions, the production of extracellular adenosine may originate from astrocytes or neurons. First, virus-mediated knockdown of astrocyte plasma membrane Ca2+ was used. 2+ The pump PMCA2 was used to determine whether astrocytes are the primary cellular source of adenosine release induced by 40 Hz flash stimulation. hPMCA2w / b is a plasma membrane Ca2+ ratio. 2+ The subtype of pump PMCA functions to constitutively extrude cytoplasmic calcium. 2+ It can reduce calcium in astrocytes 2+ Signals, reducing their activity (e.g.) Figure 14A). We injected a 1:1 mixture of AAV2 / 9-GfaABC1D-mCherry-hPMCA2w / b and AAV2 / 9-ShortGFAP-Gcamp6 into the V1 region of mice, and waited for virus expression for 2 weeks. Then, we used the plantar shock experiment method (e.g.) Figure 14 B), verifying that this virus mediates the knockdown of astrocyte plasma membrane Ca2+. 2+ The feasibility of pumping PMCA2. Experimental results showed that after plantar electric shock, compared with the control side (AAV2 / 9-GfaABC1D-mCherry), astrocyte reactivity was significantly reduced by 40%, indicating that the virus can indeed reduce the activity of astrocytes (e.g., Figure 14 C).
[0194] To investigate whether astrocytes promote adenosine release during 40 Hz flash, mice injected with AAV2 / 9-GfaABC1D-mCherry-hPMCA2w / b virus were simultaneously injected into the V1 region with AAV2 / 9-GfaABC1D-mCherry-hPMCA2w / b and AAV2 / 9-hsyn-GRABAdo1.0 (mixed 1:1). Figure 15 A) Two weeks after viral expression, the cells were subjected to 40 Hz flash stimulation, and changes in adenosine concentration were recorded in real time. The results showed that 40 Hz flash stimulation reduced the increase and changes in active adenosine concentration in mouse V1 astrocytes, and these changes were characteristic of the experimental group (plasma membrane Ca2+). 2+ PMCA2 knockdown mice and control mice (plasma membrane Ca2 knockdown mice) 2+ The pump PMCA2 in normal mice was almost identical ( Figure 15 (BC) indicates that the extracellular adenosine increase from 40 Hz flash stimulation does not primarily originate from astrocytes.
[0195] To elucidate that neurons are the primary cellular source of extracellular adenosine levels induced by 40Hz flash stimulation, we specifically lesed V1 neurons using Caspase-3 and measured changes in adenosine concentration during 40Hz flash stimulation. AAV2 / 9-hsyn-GRABAdo1.0 and rAAV-hSyn-taCasp3-T2A-TEVp were mixed at a 1:1 ratio and injected into the V1 region of mice. After two weeks of viral expression, a significant reduction in the number of V1 neurons was observed by fluorescent staining. Then, 40Hz flash stimulation was performed, and changes in adenosine concentration were recorded in real time. The results showed that in control mice (with normal V1 neurons), extracellular adenosine levels increased significantly during 40Hz flash stimulation, while in mice lacking V1 neurons, no increase in extracellular adenosine was observed during 40Hz flash stimulation intervention. Figure 16(AB). This demonstrates that neurons in region V1 play an important regulatory role in increasing extracellular adenosine concentration in response to 40Hz flash stimulation.
[0196] Example 12. Spectacles that regulate adenosine release like Figure 17 As shown, the main components of the device include: a miniature LED display screen, a housing, a flexible circuit board, an inner cover, and left and right sideburn clips. The device is shaped like a pair of glasses and primarily serves two functions: (A) LED light groups of different wavelengths are fixedly clamped between the housing and the inner cover of the glasses. Flexible circuit boards are distributed around the display screen along the edge of the frame, allowing for free adjustment of various combinations of flashing stimulation, including different wavelengths, frequencies, light intensities, and durations. (B) The miniature LED display screen is positioned over the lenses of the glasses to display the optimal visual stimulation image selected based on visual stimulation, adenosine concentration, and sleep changes. These two modes are superior to visual stimulation devices with fixed flashing intensity and frequency on the market, greatly reducing the discomfort caused by simple flashing stimulation and pioneering a new direction in visual stimulation image therapy for sleep disorders.
Claims
1. A device for improving sleep disorders, characterized in that, Includes a stimulus generator for generating (a) a 1-100 Hz flash, (b) a full-screen visual stimulus, and / or (c) a 1-100 Hz sound.
2. The apparatus according to claim 1, wherein, The stimulation generator includes a visual stimulation generator and / or an auditory stimulation generator; Optionally, the visual generator emits visual stimuli in the range of 20-80 Hz; optionally, the visual stimulus frequency includes one or more of the following frequencies: 20 Hz, 25 Hz, 30 Hz, 35 Hz, 40 Hz, 45 Hz, 50 Hz, 55 Hz, 60 Hz, 65 Hz, 70 Hz, 75 Hz, and 80 Hz. Optionally, the visual stimulus frequency includes 30-60 Hz; or, optionally, the visual stimulus frequency includes one or more of 30 Hz, 35 Hz, 40 Hz, 45 Hz, 50 Hz, 55 Hz and 60 Hz. Optionally, the visual stimulus frequency includes 35-45 Hz; or, optionally, the visual stimulus frequency includes one or more of 35 Hz, 40 Hz, and 45 Hz. Optionally, the visual stimulus frequency is 40 Hz; Optionally, the white light illuminance of the visual stimulus is above 2000 lux; Optionally, the wavelength of the monochromatic light used for the visual stimulus is 480~530nm; Optionally, the duty cycle of the visual stimulus is 20%-80%, preferably 30%-70%, or 40%-70%, or 45-55%; Optionally, the duty cycle of the visual stimulus is selected from one or more of 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75% and 80%. Optionally, the duty cycle of the visual stimulus is 50%.
3. The apparatus according to claim 2, wherein, The visual stimulus generator includes a lamp and / or a display screen; Optionally, the lamp includes a CCFL lamp, an LED lamp, and / or an OLED lamp; Optionally, the display screen includes a CCFL display screen, an LED display screen, and / or an OLED display screen.
4. The apparatus according to claim 3, wherein, The lamp emits white light and / or monochromatic light; Optionally, the monochromatic light includes one or more of ultraviolet light, blue light, green light, red light and near-infrared light, preferably blue light and / or green light; Optionally, the center wavelength of the ultraviolet light is 315-400 nm, 320-395 nm, 325-390 nm, or 330-385 nm; preferably 380 nm; Optionally, the center wavelength of the blue light is 450~490nm, or 455~488nm, or 460~485nm; preferably 480nm. Optionally, the center wavelength of the green light is 500nm~560nm, or 505nm~555nm, or 510nm~550nm, or 515nm~545nm, or 520nm~540nm, or 525nm~545nm, or 530nm~535nm; preferably 530nm. Optionally, the center wavelength of the red light is 600~680 nm, or 595~675 nm, or 590~670 nm, or 585~665 nm, or 580~650 nm; preferably, 650 nm. Optionally, the center wavelength of the near-infrared light is 780~1100 nm, or 790~1090 nm, or 800~1080 nm, or 810~1070 nm, or 820~1060 nm, or 830~1050 nm, or 840~1040 nm, or 850~1030 nm; preferably 850 nm. Optionally, the white light illuminance is 2-6000 Lux, and the monochromatic light illuminance is 2-500 Lux; Optionally, the illuminance of the white light emitted by the lamp is 500-3000 Lux. Optionally, the illuminance of the white light emitted by the lamp includes one or more of 500 Lux, 1000 Lux, 2000 Lux and 3000 Lux.
5. The apparatus according to claim 3 or 4, wherein, The display screen shows a raster image; optionally, the contrast of the raster image is 10%-100%. Optionally, the raster image includes one or more of the following: motion raster image, scintillation raster image, scintillation grid image, and flipped raster image; Optionally, the contrast of the motion grating is 10%-100%; optionally, the orientation of the motion grating is 0-180°; optionally, the spatial frequency of the motion grating image is 0.05-30 cycles / deg; for example, 0.05-10 cycles / deg; optionally, the motion speed of the motion grating image is 1-10 Hz. Optionally, the contrast ratio of the flip grating is 10%-100%; optionally, the flip frequency of the flip grating is 20-60Hz or 30-50Hz, preferably 40Hz; optionally, the spatial frequency of the flip grating is 0.1-30 cpd or 0.1 cpd; optionally, the contrast ratio of the flip grating is 10%-100%, 70-90%, preferably 80%; optionally, the average brightness of the flip grating is 100~500 cd / m². 2 Or 140-180 cd / m 2 or 150-170 cd / m 2 or 160 cd / m 2 ; Optionally, the contrast of the flashing grid image is 10%-100%; optionally, the frequency of the flashing grid image is 1-100 Hz; optionally, the grid size of the flashing grid image is 0.5-10 deg.
6. The apparatus according to any one of claims 1-5, wherein, The device includes a mobile phone, tablet, or portable wearable device.
7. The apparatus according to claim 6, wherein, The portable wearable device is selected from glasses, goggles, face masks, hats, headbands, helmets, bracelets, or watches; optionally, the glasses include VR glasses.
8. The apparatus according to claim 7, wherein, The portable wearable device includes a frame; optionally, the portable wearable device also includes temples or a headband. Optionally, a light is provided at the edge of the lens surrounded by the frame; optionally, the light includes a CCFL light, an LED light, and / or an OLED light; Optionally, a display screen is provided at the center of the lens surrounded by the frame; optionally, the display screen includes a CCFL display screen, an LED display screen, and / or an OLED display screen; Optionally, the lamp includes a monochromatic lamp and a white lamp; Optionally, the illuminance of the monochromatic lamp is 2-500 lux; optionally, the illuminance of the white lamp is 2-6000 lux. Optionally, the lamp includes blue light, green light, red light and white light.
9. The apparatus according to claim 8, wherein, The display screen displays a raster image, which includes a vertical motion raster, a horizontal motion raster, and / or a flashing raster. Optionally, the vertical motion grating parameter is 0° orientation; optionally, the vertical motion grating spatial frequency is 0.2 cpd; optionally, the vertical motion grating temporal frequency is 1 Hz; optionally, the vertical motion grating contrast is 50%. Optionally, the horizontal motion grating parameter is oriented at 90°; optionally, the horizontal motion grating spatial frequency is 0.2 cpd; optionally, the horizontal motion grating temporal frequency is 1 Hz; optionally, the horizontal motion grating contrast is 50%.
10. The apparatus according to any one of claims 1-9, wherein, The improvement of sleep disorders includes any one or more of the following: (1) Shorten sleep latency; (2) Extend total sleep time; (3) Improve sleep efficiency; (4) Reduce the time spent awake after falling asleep; (5) Shorten REM sleep latency; (6) Increase the proportion of REM sleep; Optionally, the device improves sleep disorders through visual stimulation at 20-80 Hz; Optionally, the device improves sleep disorders through 30-60 Hz visual stimulation; Optionally, the device improves sleep disorders through 35-45 Hz visual stimulation; Optionally, the device improves sleep disorders through 40 Hz visual stimulation.
